echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: ChAdOx1-nCoV-19 vaccine induced immune thrombotic thrombocytopenia characterized by ischemic stroke

    JNNP: ChAdOx1-nCoV-19 vaccine induced immune thrombotic thrombocytopenia characterized by ischemic stroke

    • Last Update: 2021-06-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In ChAdOx1 nCoV-19 encoding SARS-CoV-2.


    Immune Thrombosis Here, this article reports three VITT patients with ischemic stroke.


    Patient 1, a 35-year-old Asian female, had onset of right temporal and periorbital headache a few days after receiving ChAdOx1-nCoV-19 vaccine.


    Blood vessel

    Patient's cerebrovascular impact

    Patient's cerebrovascular impact

    Person 2 was a 37-year-old white female who developed diffuse headache, loss of left visual field, confusion, and left arm weakness 12 days after the ChAdOx1 nCoV-19 vaccine.


    Patient 3, a 43-year-old Asian male, developed a language barrier 21 days after the ChAdOx1 nCoV-19 vaccine.


    Observations have shown that in addition to venous thrombosis, the clinical symptoms of VITT include arterial occlusion.


    Management includes intravenous immunoglobulin, methylprednisolone, plasma exchange, and non-heparin anticoagulants such as fondaparinux, argatroban, or direct oral anticoagulants.
    Endovascular treatment or decompressive craniectomy can also be used for carefully selected patients Al-MayhaniT ,SaberS ,StubbsMJ Al-MayhaniT Al-Mayhani SaberS Saber StubbsMJ Stubbs , et al bmj.
    com/content/early/2021/05/20/jnnp-2021-326984" target="_blank" rel="noopener">Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopaenia Journal of Neurology, Neurosurgery & Psychiatry  Published Online First:  25 May 2021.
      Published Online First: doi: 10.
    1136/jnnp-2021-326984 doi:

    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.